Companies: 10,795·Total market cap: $144.5T
RAPT Therapeutics, Inc.

RAPT Therapeutics, Inc.

RAPTNASDAQHealthcare
$58.01
+$0.00(+0.00%)
Market Cap$959257107
P/E Ratio
52W High$58.02
52W Low$5.6652
Overview

RAPT Therapeutics, Inc. (RAPT) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · RAPT · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-11.07rapt eps ttm · rapt earnings per shareEarnings history
PE Ratio (TTM)rapt pe ratio ttm · rapt price to earningsPE Ratio deep dive
Revenue (TTM)0.00rapt revenue ttm · rapt annual revenueFull revenue history
Dividend YieldNo Dividenddoes rapt pay dividends · rapt dividend yieldDividend history
Shares Outstanding5.1Mrapt shares outstanding · rapt floatShares outstanding history
Next EarningsTBArapt earnings date · rapt next earningsEarnings history

Financial Snapshot

Full Financials
FY 2024Revenue$0.00
202220232024
rapt therapeutics, inc. revenue · rapt revenue 2024
FY 2024Net Income-$129.9M▼ 11.19% YoY
202220232024
rapt therapeutics, inc. net income · rapt profit 2024
FY 2024EPS$-25.49▼ 4.58% YoY
202220232024
rapt eps · rapt therapeutics, inc. earnings per share 2024
TTM:Revenue: $0.00Net Income: -$105.6MEPS: $-11.07View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold15 analystsis rapt a buy · rapt analyst rating
Strong Buy
0
Buy
4
Hold
11
Sell
0
Strong Sell
0
12-Month Price Target
$58.00Low
$58.01Current
$58.00Avg Target0.01% downside
$58.00High
rapt price target · rapt 12 month forecast

Total: 15 · Buy rate: 26.7%

The RAPT analyst consensus is Hold, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $58.00, representing -0.01% downside from the current price of $58.01.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M-0.01%
3M+94.52%
YTD+82.12%
1Y+590.54%
5Y-68.80%

About RAPT Therapeutics, Inc.

CEOBrian Russell Wong
IPO DateOct 31, 2019
Employees67
CountryUS
Websiterapt.com

RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical firm specializing in immunology. The company is dedicated to discovering, developing, and commercializing innovative oral small molecule t…

what is rapt therapeutics, inc. · rapt stock overview · rapt therapeutics, inc. company profile · who is rapt therapeutics, inc. ceo · rapt NASDAQ · rapt therapeutics, inc. headquarters · rapt therapeutics, inc. business segments

About Stock Overview & Key Data

RAPT Therapeutics, Inc. (RAPT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 31, 2019. As of the latest trading session, RAPT stock price is $58.01, with a market capitalization of $959.3M. The stock has returned +590.54% over the past 12 months and +82.12% year-to-date.

According to 15 Wall Street analysts, the consensus rating for RAPT Therapeutics, Inc. stock is Hold, with an average 12-month price target of $58.00. In fiscal year 2024, RAPT Therapeutics, Inc. reported revenue of — and net income of -$129.9M. For detailed data — including RAPT Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, RAPT Therapeutics, Inc. (RAPT) stock price is $58.01. The stock is traded on NASDAQ under the ticker symbol RAPT. The 52-week range is $5.67 – $58.02.

RAPT stock priceRAPT quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice